Urban Wealth Management »

Chemomab Therapeutics shares owned by Urban Wealth Management

Quarter-by-quarter ownership of Chemomab Therapeutics (CMMB) shares owned by Urban Wealth Management from 13F filings

Historical chart of Urban Wealth Management investment in Chemomab Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Chemomab Therapeutics held by Urban Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chemomab Therapeutics by Urban Wealth Management

Quarter filed Position value Share count Share price at filing
2022-06-30 $10k 2.8k 3.62

More positions owned by Urban Wealth Management

Alphabet Cap Stk Cl A (GOOGL)
Verizon Communications (VZ)
Ishares U S Etf Tr Commodity Curve (CCRV)
DaVita (DVA)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Us Infrastruc (IFRA)
Spdr Ser Tr Portfolio Ln Tsr (SPTL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
salesforce (CRM)
American Tower Reit (AMT)
Nushares Etf Tr Nuveen Esg Midvl (NUMV)
NVIDIA Corporation (NVDA)
Ishares Tr Core High Dv Etf (HDV)

View all positions for Urban Wealth Management

Top funds holding Chemomab Therapeutics

OrbiMed Advisors
Sphera Funds Management
Yelin Lapidot Holdings Management
Ikarian Capital
Two Sigma Securities
Kestra Private Wealth Services
Boothbay Fund Management
Rhumbline Advisers
XTX Topco
Hrt Financial
Millennium Management
Wetzel Investment Advisors
GAMMA Investing
UBS Group
Jpmorgan Chase & Co

View all funds holding Chemomab Therapeutics